Advance Search
WU Jianyue, NI Yingjie, RUI Yufeng, XU Lin, ZHANG Dong. A clinical analysis of hidden blood loss in elderly patients with intertrochanteric fracture of femur during perioperative period[J]. Journal of Clinical Medicine in Practice, 2022, 26(4): 60-63. DOI: 10.7619/jcmp.20213220
Citation: WU Jianyue, NI Yingjie, RUI Yufeng, XU Lin, ZHANG Dong. A clinical analysis of hidden blood loss in elderly patients with intertrochanteric fracture of femur during perioperative period[J]. Journal of Clinical Medicine in Practice, 2022, 26(4): 60-63. DOI: 10.7619/jcmp.20213220
shu

A clinical analysis of hidden blood loss in elderly patients with intertrochanteric fracture of femur during perioperative period

  • 1.

    Department of Orthopedics, Wuxi City Xishan People's Hospital of Jiangsu Province, Wuxi, Jiangsu, 214102

  • 2.

    Department of Orthopedics, Zhongda Hospital Affiliated to Southeast University, Nanjing, Jiangsu, 210009

More Information
  • Received Date: August 09, 2021
  • Available Online: March 21, 2022
  • Published Date: February 27, 2022
    Graphical Abstract
    • Abstract
  •   Objective  To analyze the related factors of hidden blood loss in elderly patients with intertrochanteric fracture of femur (IFF) during perioperative period.
      Methods  A total of 110 elderly patients with IFF who received surgical treatment were selected as research subjects, the hidden blood loss of patients was recorded on the first day before admission and third day after operation, the baseline data filling form was designed to record the related baseline data of patients, the hidden blood loss of patients with different characteristics of data was compared, the related factors that might affect the hidden blood loss in elderly patients with IFF were analyzed.
      Results  Of 110 elderly patients with intertrochanteric fracture of femur, the average total perioperative blood loss was (913. 62±169.84) mL, and the preoperative hidden blood loss was (254.91±57.83) mL and the hidden blood loss was (795.20±128.75) mL; the hidden blood loss of elderly patients with IFF combined with underlying diseases, type A3 of fracture, intramedullary fixation and general anesthesia was higher than that of patients without underlying diseases, type A1 and A2 of fracture, extramedullary fixation, the differences were statistically significant (P < 0.05); there was no statistically significant difference in the amount of hidden blood loss in elderly IFF patients with differed characteristics during perioperative period (P>0.05); the results of multiple linear regression analysis showed that combining with underlying diseases, type A3, intramedullary fixation were the influencing factors of more hidden blood loss in elderly patients with IFF (P < 0.05).
      Conclusion  Combining with underlying diseases, type A3 of fracture, and intramedullary fixation are the influencing factors of hidden blood loss in elderly patients with IFF.
    • FullText(HTML)
    • References (18)
  • [1]
    DAI C Q, WANG L H, ZHU Y Q, et al. Risk factors of perioperative blood transfusion in elderly patients with femoral intertrochanteric fracture[J]. Medicine, 2020, 99(15): e19726. doi: 10.1097/MD.0000000000019726
    [2]
    卢遥, 何金山, 周岳来, 等. 低分子量肝素钙对股骨近端防旋髓内钉治疗股骨粗隆间骨折隐性失血和深静脉血栓形成的影响[J]. 实用临床医药杂志, 2019, 23(5): 76-79. doi: 10.7619/jcmp.201905021
    [3]
    ZHANG R, YANG Z Q, LEI T, et al. Effects of aminocaproic acid on perioperative hidden blood loss in elderly patients with femoral intertrochanteric fracture treated with proximal femoral nail anti-rotation[J]. J Int Med Res, 2019, 47(10): 5010-5018. doi: 10.1177/0300060519872037
    [4]
    胡亚力, 刘烔, 罗富健, 等. 老年后路腰椎椎体间植骨融合术后隐性失血的危险因素分析[J]. 医学综述, 2020, 26(10): 2061-2064, 2069. doi: 10.3969/j.issn.1006-2084.2020.10.036
    [5]
    管军辉, 郑文标, 黄皆和, 等. 骨质疏松性椎体压缩性骨折椎体后凸成形术后隐性失血及其影响因素分析[J]. 中国骨伤, 2019, 32(5): 439-443. doi: 10.3969/j.issn.1003-0034.2019.05.010
    [6]
    CHRISTOS G, KANAKARIS N K, LASANIANOS N G, et al. New classification system for long-bone fractures supplementing the AO/OTA classification[J]. Orthopedics, 2012, 35(5): e709-e719.
    [7]
    陈孝平, 汪建平, 赵继宗. 外科学[M]. 9版. 北京: 人民卫生出版社, 2018: 657-665.
    [8]
    《中国高血压基层管理指南》修订委员会. 中国高血压基层管理指南(2014年修订版)[J]. 中国医学前沿杂志: 电子版, 2015, 7(7): 18-40. doi: 10.3969/j.issn.1674-7372.2015.07.005
    [9]
    中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2007年版)[J]. 中华医学杂志, 2008, 88(18): 1227-1245. doi: 10.3321/j.issn:0376-2491.2008.18.002
    [10]
    李长江, 吕欣, 张建国, 等. 股骨转子间骨折围手术期隐性失血的研究进展[J]. 实用骨科杂志, 2019, 25(11): 996-999. https://www.cnki.com.cn/Article/CJFDTOTAL-SGKZ201911010.htm
    [11]
    NIKOLAOU V S, MASOUROS P, FLOROS T, et al. Single dose of tranexamic acid effectively reduces blood loss and transfusion rates in elderly patients undergoing surgery for hip fracture: a randomized controlled trial[J]. Bone Jo J, 2021, 103-B(3): 442-448. doi: 10.1302/0301-620X.103B3.BJJ-2020-1288.R1
    [12]
    陈阳, 袁义, 章海均, 等. 老年股骨转子间骨折隐性失血研究的新进展[J]. 中国组织工程研究, 2019, 23(20): 3207-3212. doi: 10.3969/j.issn.2095-4344.1198
    [13]
    JIANG C, CHEN T H, CHEN Z X, et al. Hidden blood loss and its possible risk factors in cervical open-door laminoplasty[J]. J Int Med Res, 2019, 47(8): 3656-3662. doi: 10.1177/0300060519856987
    [14]
    高志祥, 刘春花, 黄卫民. 脊柱手术围手术期隐性失血原因分析[J]. 实用骨科杂志, 2018, 24(3): 243-247. https://www.cnki.com.cn/Article/CJFDTOTAL-SGKZ201803019.htm
    [15]
    朱江龙, 章晓云, 陈跃平, 等. PFNA治疗老年股骨粗隆间骨折隐性失血的相关因素分析[J]. 中国骨与关节损伤杂志, 2019, 34(4): 374-376. https://www.cnki.com.cn/Article/CJFDTOTAL-GGJS201904012.htm
    [16]
    李志鲲, 沈光思, 李一凡, 等. 老年髋部骨折术后隐性失血量的影响因素分析[J]. 现代仪器与医疗, 2018, 24(3): 70-71, 110. https://www.cnki.com.cn/Article/CJFDTOTAL-XDYI201803029.htm
    [17]
    张俊, 厉国定, 尹伟忠, 等. 髓外与髓内固定治疗高龄稳定股骨粗隆间骨折围手术期隐性失血的对比研究[J]. 生物骨科材料与临床研究, 2019, 16(6): 39-43. doi: 10.3969/j.issn.1672-5972.2019.06.009
    [18]
    顾小明, 包洪卫, 吴灿华, 等. 老年股骨粗隆间骨折手术隐性失血的危险因素分析[J]. 中国矫形外科杂志, 2015, 23(22): 2038-2042. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJXS201522008.htm
    • Related Articles

  • Related Articles

    [1]WANG Mingbang, CHEN Changsha, LIU Rongzhen, XU Jianfeng. Effect of transurethral plasmakinetic resection of prostate in treating benign prostatic hyperplasia complicated with hypertension[J]. Journal of Clinical Medicine in Practice, 2024, 28(15): 90-94. DOI: 10.7619/jcmp.20241211
    [2]LI Meng, ZHANG Wenfeng, WU Wenfeng, JIANG Tao, WEN Lili. Transurethral green laser enucleation of prostate versus transurethral vaporization of prostate in treatment of severe benign prostatic hyperplasia[J]. Journal of Clinical Medicine in Practice, 2023, 27(2): 113-116, 121. DOI: 10.7619/jcmp.20214804
    [3]WU Haoming, FU Guangbo. Clinical significance of long non-coding RNA SChLAP1 expression in prostate cancer tissue and its relationship with prognosis[J]. Journal of Clinical Medicine in Practice, 2022, 26(5): 30-33. DOI: 10.7619/jcmp.20214427
    [4]PAN Kai, SHEN Yuyong, ZHOU Hai, CHEN Yuming, QI Lezhong, FAN Qibing, QI Tingyue, WANG Xiaoxiang. Modified holmium laser enucleation of the prostate versus transurethral resection of prostate in treatment patients with large volume prostatic hyperplasia[J]. Journal of Clinical Medicine in Practice, 2020, 24(11): 21-24. DOI: 10.7619/jcmp.202011006
    [5]DONG Xinqiang, SUN Wengong, CUI Hongquan, PENG Yingke. Effect of dilatation surgery of prostate on sexual function in benign prostatic hyperplasia patients[J]. Journal of Clinical Medicine in Practice, 2020, 24(2): 65-67. DOI: 10.7619/jcmp.202002019
    [6]ZHANG Shaojie, XU Xiaofeng, DU Quan, LI Nan, XIAO Xiang. Effect of transurethral plasma bipolar resection of prostate on urodynamics and serum levels of prostate specific antigen, epidermal growth factor and prostaglandin E2 in patients with benign prostatic hyperplasia[J]. Journal of Clinical Medicine in Practice, 2019, 23(18): 79-83. DOI: 10.7619/jcmp.201918023
    [7]ZENG Hanyun. Clinical nursing pathway in treating benign prostatic hyperplasia patients with transurethral resection[J]. Journal of Clinical Medicine in Practice, 2019, 23(13): 123-125, 128. DOI: 10.7619/jcmp.201913035
    [8]ZHOU Cuiyu, LIU Weihua. Evidence-based nursing for transurethral resection of prostate in elderly patients underwent benign prostatic hyperplasia[J]. Journal of Clinical Medicine in Practice, 2019, 23(7): 116-120. DOI: 10.7619/jcmp.201907031
    [9]WANG Yongheng, ZHANG Xueguang. Effect of transurethral plasma prostate gland resection on the treatment of benign prostatic hyperplasia[J]. Journal of Clinical Medicine in Practice, 2018, (7): 99-101. DOI: 10.7619/jcmp.201807027
    [10]LUO Qing, JIANG Jinxiong, CAO Xiaozhen, XIAO Qinghua. Differential diagnostic value of transrectal ultrasound combined with PSAD on prostate cancer and benign prostate hyperplsia[J]. Journal of Clinical Medicine in Practice, 2013, (13): 156-158. DOI: 10.7619/jcmp.201313057

  • Cited by

    Periodical cited type(2)

    1. 喻洁明，任荣飞，陈晓亮. 耳内镜下应用耳屏软骨-软骨膜复合体行Ⅰ型鼓室成形术的临床疗效研究. 中国医学文摘(耳鼻咽喉科学). 2024(01): 130-132+108 .
    2. 包勇正，邹文兰，胡志邦，马敬. 29例鼓膜大穿孔患者耳内镜下鼓膜成形术疗效观察. 实用临床医药杂志. 2020(23): 42-44 . 本站查看

    Other cited types(0)

Catalog

    Get Citation
    PDF
    XML
    Article views (241) PDF downloads (21) Cited by(2)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return